MafK Antibody (381923) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3809E
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 381923
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human MafK
Thr2-Ser156
Accession # O60675
Thr2-Ser156
Accession # O60675
Specificity
Detects human and mouse MafK in Western blots. In Western blots, no cross-reactivity with recombinant human (rh) MafB or rhMafF is observed. In Western blots, prolonged film exposures may slightly detect rhMafG.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for MafK Antibody (381923) [DyLight 405]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MafK
Long Name
v-maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog K
Alternate Names
NFE2U
Gene Symbol
MAFK
Additional MafK Products
Product Documents for MafK Antibody (381923) [DyLight 405]
Product Specific Notices for MafK Antibody (381923) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...